We invite all young breast cancer survivors to join us and your Big Pink Footprint community for an afternoon developed to empower women under 40 for the upcoming season of family, friends and celebrating. Our expert panel will also discuss important issues you told us are important to you as you journey through life after breast cancer. Highlights include:
- Peer interaction & Lunch (catered by the Couch Tomato Cafe)
- New Genes Linked to Breast Cancer Risk. Presented by Dr. Susan M. Domchek, Executive Director, Basser Research Center; Director, MacDonald Women's Cancer Risk Evaluation Center; Basser Professor in Oncology
- New Imaging Techniques, Specific Research That's Going on at the University of Pennsylvania as a Result of Komen Funding. Presented by Dr. David Mankoff, Professor of Radiology, Penn Medicine, Perelman School of Medicine, University of Pennsylvania Health System.
- Audience Q&A on our physician presentations
- Looking Hot – and Shopping Smart – for the Season. Presented by Sandy Kim, Regional Director for Macy's By Appointment for Mid-Atlantic
ONLINE REGISTRATION IS NOW OPEN
- Registration is required Register now.
- Registration deadline: October 25
More Big Pink Footprint Opportunities
- Learn more about The Big Pink Footprint, a unique, year-round program developed by Komen Philadelphia & our young survivor leadership.
- Explore photos from our summer Living Confident event and our 2014 Race for the Cure Big Pink Footprint activities
Thank you to our Sponsor
About our Panelists
Dr. Susan M. Domchek
Dr. Susan M. Domchek graduated summa cum laude from Dartmouth College in 1990. In 1993, she was selected as a Marshall Scholar and spent a year studying English Literature at Oxford University. She went on to graduate magna cum laude from Harvard Medical School in 1995, and completed a residency in Internal Medicine at Massachusetts General Hospital where she was named Chief Medical Resident. Dr. Domchek then completed a hematology/oncology fellowship at Dana-Farber Cancer Institute. Since joining the Abramson Cancer Center in 2001, Dr. Domchek has committed herself to pursuing novel research in breast and ovarian cancers, particularly related to genetic factors contributing to their development. Dr. Domchek is a Basser Professor of Medicine at the University of Pennsylvania, Executive Director of the Basser Research Center for BRCA; and the Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Center at the Abramson Cancer Center and a Senior Fellow at the Leonard Davis School of Health Economics. Dr. Domchek has authored/coauthored more than 100 articles appearing in scholarly journals and serves on a number of editorial review boards including the NCI PDQ in Cancer Genetics, and is also a member of the Komen for the Cure Scientific Advisory Council. Dr. Domchek has committed herself to pursuing novel research in clinical applications of genetic susceptibility to breast and ovarian cancer, particularly with regard to risk assessment, screening, prevention, and treatment. She is particularly interested in the development of targeted therapeutics in this population, as well as the long term intact of risk reducing interventions. She has served on the Editorial Board for the National Cancer Institute PDQ summary in Breast Cancer Genetics as well as several committees for the American Society of Clinical Oncology.
Dr. David Mankoff
Dr. David Mankoff is Gerd Muehllehner Professor of Radiology , Chief of the Division of Nuclear Medicine Clinical Molecular Imaging, and Director of the PET Center at the Perelman School of Medicine at the University of Pennsylvania. Dr. Mankoff is board-certified in Nuclear Medicine and holds a PhD in Bioengineering focusing on PET instrumentation. He practices Nuclear Medicine at the University of Pennsylvania, with a special interest in oncologic and endocrine applications of molecular imaging and treatment of endocrine tumors. Dr. Mankoff’s research focuses on molecular imaging of cancer, primarily on breast cancer, and emphasizes therapeutic monitoring and identifying factors mediating therapeutic resistance and translation of new methods to clinical trials. Dr. Mankoff is a Komen Scholar for the Susan G. Komen Foundation. He also Chairs the Experimental Imaging Sciences Committee and serves as Co-Chair of the Scientific Program Committee of ECOG-ACRIN. Dr. Mankoff is a past member and Chairman of the American Board of Nuclear Medicine. Dr. Mankoff is on the editorial boards of Nuclear Medicine and Biology, Breast Cancer Research, Journal of Nuclear Medicine, The Breast Journal, and Clinical Cancer Research and serves as an Associate Editor for Breast Cancer Research and Journal of Nuclear Medicine.